Live Chat

The Actos Risk Spike

Actos (pioglitazone) doesn’t simply have risks. This commonly prescribed drug for patients suffering from Type-2 diabetes features a risk spike beginning around the twelfth month of a patient’s treatment. As patients enter a second year of pioglitazone treatments, there probability for suffering from side effects elevates considerably. Bladder cancer, for instance, occurs at a significantly more frequent basis for longer-term consumers.

 

Has your loved one suffered from Actos side effects? If the answer is yes, it may be time to speak with the professionals and dedicated attorneys at Fears Nachawati. With years of experience handling claims like those of your family, we know the questions to ask, the answers to seek, and the evidence to accumulate. Contact our dedicated attorneys today. With years of experience, we know how to protect clients just like you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Categories
Drug Litigation

The Actos Risk Spike